Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 6,466
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
JULIET SSEMATIMBA
ID:
INDIGENOUS SALT MAKING TECHNOLOGY AT KIBIRO SALT GARDENS IN BUNYORO 1894-2015.
REFNo: SS1450ES

The main objective of the study is to investigate and discuss the historical trends of indigenous salt making technology , its persistence and how that shapes the gender relation at kibiro salt gardens.
 Uganda 2022-10-21 17:04:00 2025-10-21 Social Science and Humanities Non-Clinical Trial Degree Award
Jemimah Kyeyune Kiboss
ID: UNCST-2021-R013163
 Prevalence of Metabolic Syndrome and Associated Factors Among Corporate Company Employees in Uganda
REFNo: HS2098ES

III. To determine the lifestyle factors associated with metabolic syndrome among corporate company employees in Kampala.,II. To identify individual factors associated with metabolic syndrome among corporate company employees in Kampala.,I. To assess the prevalence of metabolic syndrome among corporate employees in Kampala.,The main aim of this study will be to evaluate the prevalence of metabolic syndrome and its associated factors among corporate company employees in Kampala, Uganda.,I. To assess the prevalence of metabolic syndrome among corporate employees in Kampala. II. To identify individual factors associated with metabolic syndrome among corporate company employees in Kampala. III. To determine the lifestyle factors associated with metabolic syndrome among corporate company employees in Kampala.,
 Kenya 2022-10-21 17:01:28 2025-10-21 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Patrick Opondo
ID: UNCST-2022-R010446
 A Monitoring and Evaluation of Managing Animal Health and Acaricides for a Better Africa (MAHABA): A landscaping study in Uganda
REFNo: A233ES

Assess protocols selected in controlling ticks and tickborne diseases, Assess acaricide availability to the farmers ,Assess extent of farmer observed acaricide resistance and treatment failures, Determine farm size and management systems of farmers, Determine the number and proportion of farmers using acaricides ,Assess other production constraints among farmers ,Assess the cost controlling of ticks and tick borne diseases among farmers, Assess farmers practices, knowledge, perceptions, attitudes and challenges on use of acaricide products for cattle in the control of Ticks and tickborne diseases in selected districts of Uganda with high burden of ticks and tickborne diseases, Assess the role of gender in ticks and tick borne disease management, Assess opportunities for developing new routes for communication, Determine sources of information on acaricides, ticks and tickborne diseases
 Uganda 2022-10-21 14:11:50 2025-10-21 Agricultural Sciences Non-Clinical Trial Non-degree Award
Fredrick Kabi
ID:
EVALUATION OF THE SAFETY, EFFICACY AND EFFECTIVENESS OF THE SUBOLESIN BASED ANTI-TICK VACCINE: A RANDOMISED DOUBLE BLINDED MULTI-SITE CONFINED FIELD TRIAL
REFNo: A191ES

OVERALL OBJECTIVE
Evaluation of the Safety, Efficacy and Effectiveness of Subolesin based Anti-tick Vaccine for control of ticks naturally infesting different cattle breeds under confined field conditions in Uganda.

SPECIFIC OBJECTIVES
I. To determine the safety of the injectable Subolesin based Anti-tick vaccine for control of tick infestations under natural confined field conditions.
II. To determine the efficacy of the injectable Subolesin based Anti-tick vaccine for control of tick infestations under natural confined field conditions.
III. To determine the effectiveness of the injectable Subolesin based Anti-tick vaccine for control of tick infestations under natural confined field conditions.

 Uganda 2022-10-21 12:58:12 2025-10-21 Agricultural Sciences Clinical Trial Non-degree Award
Eugene Ruzagira
ID: UNCST-2023-R008282
 A Phase Ib trial to evaluate the safety and immunogenicity of R21/Matrix-MTM in African children living with HIV.
REFNo: HS2496ES

Primary objective a) To assess the safety and reactogenicity profile of the malaria vaccine candidate R21/Matrix-MTM in 5-36-month-old African children living with HIV Secondary objectives a) To assess the humoral immunogenicity of R21/Matrix- MTM in 5-36-month-old African children, comparing children living with HIV with HIV negative children b) To assess the impact of vaccination on HIV reservoir c) To assess whether increasing age and nadir CD4 count are associated with immunogenicity of R21/Matrix-MTM in 5-36- month-old African children living with HIV Tertiary objectives a) To assess the immunogenicity profile of R21/Matrix-MTM in 5- 36-month-old African children, comparing children living with HIV with HIV negative children
 Uganda 2022-10-20 18:13:49 2025-10-20 Medical and Health Sciences Clinical Trial Non-degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."

NRIMS